NCT00735410

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

A Phase III, Multicenter, Uncontrolled, Open-label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2008/2009 When Administered to Adult and Elderly Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 134 (actual)
• Sponsor: Novartis Vaccines · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Annual trial for registration influenza vaccine with the strain composition for season 2008/2009

Conditions

• Seasonal Influenza, Vaccine

Interventions

Type	Name	Description
BIOLOGICAL	Seasonal Influenza Vaccine	1 dose of Split influenza vaccine

Timeline

• Start date: 2008-06-01
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2008-08-15
• Last updated: 2016-12-01

Locations

1 site across 1 country: Germany